Grifols Diagnostic Solutions Inc. – FDA 483, Feb 17, 2022
An FDA inspection of Grifols Diagnostic Solutions Inc. in San Diego, CA, a licensed device/IVD establishment, revealed two significant observations. The firm failed to promptly review, evaluate, and investigate complaints for MDR-reportable events, with technical support staff providing insufficient detail for safety assessments. Additionally, procedures for design changes were found to be inadequately established, specifically concerning the risk assessment for extended onboard stability of licensed test kits and analyzer software.
ID · 00121337-e0dc-4230-baae-455a0d692b81
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.